Right Ventricular Echocardiography in caRdiac SurgEry (ReVERSE)

January 8, 2018 updated by: Lars Grønlykke, Rigshospitalet, Denmark

Response in Right Ventricular Function to Change in Afterload, Preload and Inspired Oxygen in Patients Undergoing Coronary Artery Bypass Graft Surgery

Postoperative right ventricular (RV) dysfunction increases mortality and risk of cardiac failure after cardiac surgery substantially. A comprehensive understanding of this condition is paramount in order to achieve success in treatment and early diagnosis.

This study has two main aims.

Perioperative aim:

To investigate correlations between changes in echocardiographic measurements and hemodynamic changes at baseline and following coronary artery bypass graft (CABG) surgery.

Postoperative aim:

To evaluate changes in haemodynamics and echocardiographic parameters during separate physiological interventions (increase in preload/afterload, oxygen fraction, pacing modes (AAI/DDD/VVI)).

Study Overview

Detailed Description

Clinical procedure:

For the operation standard procedures for anaesthesia, surgery and cardiopulmonary bypass will be used. This includes installment of a pulmonary artery catheter and performing a transesophageal echocardiography. For the purpose of this study additional TEE images and a transthoracic echocardiography (TTE) will be obtained in order to correlate different echocardiographic indices with haemodynamic measurements and investigate any differences between TTE and TEE measurements.

Transthoracic echocardiography (TTE):

Basic TTE will be performed after anaesthesia induction, before surgery commences and repeated immediately after arrival at the ICU.

Image acquisitions from TTE:

  • 2D apical 4-chamber view for right ventricular fractional area change (RVFAC)
  • M-mode tricuspid annular plane systolic excursion (TAPSE).
  • M-mode lateral mitral annular plane systolic excursion (MAPSE) measurements

Transoesophageal echocardiography (TEE):

After probe placement and before commencing surgery a TEE will be performed. The probe will be left in place during surgery for continuous imaging. Standard views used for patient treatment will be acquired in accordance with the requirements of the treating anaesthesiologist and surgeon.

Additional views will be added in order to obtain standard 2D measures, M-mode measures, spectral doppler measures, myocardial doppler tissue imaging, strain and 3D measures of RV function.

Measurements will be performed at different stages throughout surgery following a period of relative hemodynamic stability defined as: 1 minute of no more than 10 beats/min variation in heart rate, maximum variation of 10 mmHg in mean arterial pressure, maximum variation of 3 mmHg in central venous pressure and no change in administration of vasoactive drugs. If hemodynamic stability cannot be achieved an annotation comment will be entered.

Time points for echocardiography:

TEE will be performed at four different time points during and immediately after surgery:

Stage 1: After induction of anaesthesia. Stage 2: After full sternotomy Stage 3: After completion of cardiopulmonary bypass Stage 4: Immediately after arrival at the ICU and will be repeated after each intervention

Interventions Each intervention will be investigated separately and before each intervention the patient will return to hemodynamic baseline.

Trendelenburg position for 5 minutes will be investigated. Following positive end-expiratory pressures will be investigated: 0 cm H2O, 5 cm H2O and 10 cm H2O.

Following fractions of inspired O2 will be investigated: 0.5 and 1.0 for 10 minutes at each setting.

Following pacemaker settings will be investigated: Atrioventricular pacing 10 bpm over the patients' intrinsic rhythm, atrial pacing 10 bpm over the patients' intrinsic rhythm, ventricular pacing 10 bpm over the patients' intrinsic rhythm

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital Region
      • Copenhagen, Capital Region, Denmark, 2100
        • Rigshospitalet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Elective coronary artery bypass graft patients
  • Normal left ventricular function defined as LVEF over 50 % on TTE preoperatively

Exclusion Criteria:

  • Pre-existing right ventricular malformations
  • Severe right ventricular impairment preoperatively
  • Pre-existing non-sinus rhythm
  • Pre-existing mitral valve stenosis or severe regurgitation
  • Pre-existing pulmonary hypertension
  • Pre-existing tricuspid valve stenosis or severe regurgitation
  • Patients with contraindication to TEE probe placement such as oesophageal stricture or obstruction
  • Patients with contraindication to Swan-Ganz catheter placement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: All patients

All patients will receive the treatment (CABG) and postoperatively three different interventions:

  1. Change in preload and afterload
  2. Change in inspired oxygen
  3. Change in pacemaker modes
Afterload: Three levels of positive end-expiratory pressure (PEEP) will be examined post-operatively: 0 cm H20, 5 cm H2O, 10 cm H2O Preload: Trendelenburg position for 5 minutes will be investigated
Following fractions of inspired O2 will be investigated: 0.5 and 1.0 for 10 minutes respectively
Following pacemaker settings will be investigated: Atrioventricular pacing 10 bpm over the patients' intrinsic rhythm, atrial pacing 10 bpm over the patients' intrinsic rhythm, ventricular pacing 10 bpm over the patients' intrinsic rhythm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in right ventricular function during CABG assessed with TAPSE
Time Frame: During a standard CABG operation
Assessing the change in RV function during CABG surgery
During a standard CABG operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Right ventricular function assessed with TAPSE after each intervention
Time Frame: Immediate postoperative period
Change in TAPSE after each intervention
Immediate postoperative period
Change in cardiac output measured with Swan-Ganz during CABG
Time Frame: During a standard CABG operation
Cardiac output measured with the thermodilution technique
During a standard CABG operation
Change in cardiac output measured with Swan-Ganz after each intervention
Time Frame: Immediate postoperative period
Cardiac output measured with the thermodilution technique
Immediate postoperative period
Response in right ventricular function parameter S' to each intervention
Time Frame: Immediate postoperative period
Change in S'
Immediate postoperative period
Response in right ventricular function parameter S' during CABG
Time Frame: During a standard CABG operation
Change in S'
During a standard CABG operation
Response in right ventricular function parameter Tei index to each intervention
Time Frame: Immediate postoperative period
Change in Tei index
Immediate postoperative period
Response in right ventricular function parameter Tei index during a standard CABG operation
Time Frame: During a standard CABG operation
Change in Tei index
During a standard CABG operation
Response in right ventricular function parameter RVFAC to each intervention
Time Frame: Immediate postoperative period
Change in RVFAC
Immediate postoperative period
Response in right ventricular function parameter RVFAC during a standard CABG operation
Time Frame: During a standard CABG operation
Change in RVFAC
During a standard CABG operation
Response in left ventricular function parameter MAPSE to each intervention
Time Frame: Immediate postoperative period
Change in MAPSE
Immediate postoperative period
Response in left ventricular function parameter MAPSE during a standard CABG operation
Time Frame: During a standard CABG operation
Change in MAPSE
During a standard CABG operation
Response in right ventricular function parameter strain % to each intervention
Time Frame: Immediate postoperative period
Change in strain %
Immediate postoperative period
Response in right ventricular function parameter strain % during a standard CABG operation
Time Frame: During a standard CABG operation
Change in strain %
During a standard CABG operation
Response in right ventricular function parameter strain rate to each intervention
Time Frame: Immediate postoperative period
Change in strain rate
Immediate postoperative period
Response in right ventricular function parameter strain rate during a standard CABG operation
Time Frame: During a standard CABG operation
Change in strain rate
During a standard CABG operation
Response in right ventricular function parameter RV size to each intervention
Time Frame: Immediate postoperative period
Change in RV size
Immediate postoperative period
Response in right ventricular function parameter RV size during a standard CABG operation
Time Frame: During a standard CABG operation
Change in RV size
During a standard CABG operation
Response in right ventricular function parameter pulmonary artery flow velocity to each intervention
Time Frame: Immediate postoperative period
Change in flow velocity in pulmonary artery
Immediate postoperative period
Response in right ventricular function parameter pulmonary artery flow velocity during a standard CABG operation
Time Frame: During a standard CABG operation
Change in flow velocity in pulmonary artery
During a standard CABG operation
Response in right ventricular function parameter RVEF to each intervention
Time Frame: Immediate postoperative period
Change in RVEF measured with 3D echo
Immediate postoperative period
Response in right ventricular function parameter RVEF during a standard CABG operation
Time Frame: During a standard CABG operation
Change in RVEF measured with 3D echo
During a standard CABG operation
Response in right ventricular function parameter RVEF during CABG
Time Frame: Immediate postoperative period
Change in RVEF measured with 3D echo
Immediate postoperative period
Change in cardiac output measured with Swan Ganz in response during a standard CABG operation
Time Frame: During a standard CABG operation
Following each intervention in the postoperative period cardiac output will be measured with the thermodilution technique.
During a standard CABG operation
Change in cardiac output measured with Swan Ganz in response to each intervention
Time Frame: Immediate postoperative period
Following each intervention in the postoperative period cardiac output will be measured with the thermodilution technique.
Immediate postoperative period
Change in hemodynamic pressures in response to each intervention
Time Frame: Immediate postoperative period
Following each intervention in the postoperative period hemodynamic pressures will be measured with the Swan Ganz catheter
Immediate postoperative period
Change in hemodynamic pressures during a standard CABG operation
Time Frame: During a standard CABG operation
Following each intervention in the postoperative period hemodynamic pressures will be measured with the Swan Ganz catheter
During a standard CABG operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lars Grønlykke, MD, Rigshospitalet, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 4, 2017

Primary Completion (Actual)

October 5, 2017

Study Completion (Actual)

October 5, 2017

Study Registration Dates

First Submitted

September 19, 2017

First Submitted That Met QC Criteria

September 28, 2017

First Posted (Actual)

October 4, 2017

Study Record Updates

Last Update Posted (Actual)

January 9, 2018

Last Update Submitted That Met QC Criteria

January 8, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Right Ventricular Dysfunction

Clinical Trials on Change in preload and afterload

3
Subscribe